<< 1 >>
Top Biotechnology Blogs
Share the Top Biotechnology Blogs on
BIO SmartBrief
Abbott might acquire more companies this year, CEO says
Abbott Laboratories CEO Miles White told analysts that the company will continue to engage in acquisitions this year, despite -More- ...
Pfizer aims to reduce R&D spending by as much as $3 billion
Pfizer plans to address an overlap after its $68 billion acquisition of Wyeth by reducing spending on research and developmen -More- Genetic Engineering & Biotechnology News ranked Florida as a top US Emerging Biotechnology Cluster. Burnham, Max Planck, Scripps & Torrey Pines have selected Florida for their new East Coast operations. Learn...
Poniard will cut more than half of its staff and change exec posts
Poniard Pharmaceuticals appointed President and Chief Operating Officer Ronald Martell as CEO. -More- ...
Rewarding innovation: Deal-making, capital markets and the new payor hurdle
Registration is now open for the BIO-Windhover and Pharmaceutical Strategic Outlook, Feb. 23 to 25, 2010, in New York. -More- ...
Study links gene deletions to morbid obesity
U.K. -More- ...
Japanese researchers identify 25 potential targets for leukemia drugs
Japanese scientists found 25 DNA stretches in leukemia cells that each might serve as a target for medicines that eliminate l -More- ...
Colorado BioScience Association News Feed
Recap: Bioscience Day at the Capitol
CBSA held its second annual day at the Capitol on January 27th, featuring brief remarks from several state legislators affirming their support for the industry along with a presentation from Patrick Kelly of BIO and a panel discussion on state legislative priorities.Link to the Rocky Radar recap...
January 22, 2010 - InDevR Featured in the Boulder County Business Report
Quote from CBSA:"John Collar, chief executive and president of the Colorado Bioscience Association, applauds InDevR's efforts and intentions, noting the increasing importance of bioscience to the Colorado economy. 'We hope they stay here and grow rapidly,' he said.Collar believes InDevR's plan to fund its own growth, while difficult to execute,...
From January 15, 2010 -- Pico Tesla Featured in the Denver Business Journal
Quote from CBSA:"All medical-device makers face a big challenge in raising money to prove a new technology, said John Collar, head of the Colorado BioScience Association trade group for biotechnology and medical device companies.'There is still money out there, but you have to be lucky enough to find the investment...
The second annual "Bioscience Day at the Capitol," on Wednesday, January 27, will allow bioscience industry leaders and state legislators to discuss the industry and thoughts on the year ahead. The announcement is made by Leah Kientz, Colorado BioScience Association (CBSA) Director of Public Policy and Programs, who says "This...
Denver Magazine, January Issue: The New Health Technology
Barbara T. Zimmerman, PhD, authors "The New Health Technology" in the January Denver Magazine. John Collar, CBSA President & CEO, and CBSA Board Members Rick Duke and Kevin Smith are included.Pick up a copy on the newsstand or read online...
From November 10, 2009 - Afternoon breakout session: The Rocky Mountain Life Science Investor Conference — Who Stood Out In The Crowd and The Investor Perspective. Three company presentations from the RMLIC were heard (Leap Frogg, BioAMPS and Biodesix) and experts dissected their pitches afterward. VC Expert Panel (L-R): Michael...
About.com Biotech / Biomedical
Nanoparticles for Diagnosis of Pathogenic Infection
Scientists with NRC (National Research Council) of Canada are finding new ways to use nanotechnology, for the diagnosis of infectious diseases. They have created special "nanoprobes" that are attracted to specific pathogens, such as Salmonella or Staphylococcus aureus, clumping them together for easy testing, or reacting in a detectable manner...
Downstream Processing of Monoclonal Antibodies
When it comes to large-scale antibody production, bioprocessing companies are under constant pressure to improve yields at lower costs. Over the years affinity chromatography has been established as the protein purification method of choice for the initial purification step, when dealing with monoclonal antibodies. Current issues are being addressed by...
Can Neurodegenerative Diseases be Cured by Chaperone Induction?
Several neurodegenerative diseases, such as Parkinson's and Huntington's have been linked to the misfolding of proteins. The improper folding might not only reduce the specific activity of the protein, but may cause them to actually become neurotoxic. Research groups like Neef et al. have theorized that these diseases might be...
Protein Chaperones Ensure Structure and Function
Chaperones (or, molecular chaperones) are proteins that guide the folding of other proteins (tertiary structure) which ensures the correct protein structure and function. Also known as polypeptide chain folding proteins, they can also help guide multiple polypeptides into the correct quaternary forms. Generally they work by binding to polypeptide chains...
HDP Research Aims at Superbugs
HDPs are a group of peptides produced naturally by our bodies, for fighting microbial infection. These peptides are genetically encoded and produced by ribosomes. After the mid 90's, a whole host of functions were discovered for HDPs, including acting as signaling molecules for the immune system, having chemotactic activities on...
Notch Inhibitor Peptide Slows Tumor Formation
One of the most recent examples I could find today, of the use of a polypeptide for treatment of disease, was published in November 2009 in the journal Nature. The transcription factor (TF) known as Notch is responsible for inducing synthesis of a number of proteins, including those involved in...
Biology News Net
NIH scientists identify maternal and fetal genes that increase preterm birth risk
Researchers at the National Institutes of Health have identified DNA variants in mothers and fetuses that appear to increase the risk for preterm labor and delivery. The DNA variants were in genes involved in the regulation of inflammation and of the extracellular matrix, the mesh-like material that holds cells within...
Molecular 'firing squad' in mice triggered by overeating destroys metabolism
Overeating in mice triggers a molecule once considered to be only involved in detecting and fighting viruses to also destroy normal metabolism, leading to insulin resistance and setting the stage for diabetes. The new study, led by researchers at the Harvard School of Public Health (HSPH), specifically links together the...
Nuclear pore complexes harbor new class of gene regulators
Nuclear pore complexes are best known as the communication channels that regulate the passage of all molecules to and from a cell's nucleus. Researchers at the Salk Institute for Biological Studies, however, have shown that some of the pores' constituent proteins, called nucleoporins, pull double duty as transcription factors regulating...
First discovery of the female sex hormone progesterone in a plant
In a finding that overturns conventional wisdom, scientists are reporting the first discovery of the female sex hormone progesterone in a plant. Until now, scientists thought that only animals could make progesterone. A steroid hormone secreted by the ovaries, progesterone prepares the uterus for pregnancy and maintains pregnancy. A synthetic...
Smart coating opens door to safer hip, knee and dental implants
Researchers at North Carolina State University have developed a "smart coating" that helps surgical implants bond more closely with bone and ward off infection. ...
Bad news for mosquitoes: Yale study may lead to better traps, repellents
Yale University researchers have found more than two dozen scent receptors in malaria-transmitting mosquitoes that detect compounds in human sweat, a finding that may help scientists to develop new ways to combat a disease that kills 1 million people annually. ...
Terry Etherton Blog on Biotechnology
By Scott Kilman and Thomas Catan The Wall Street Journal Posted January 15, 2010 The U.S. Justice Department has opened a formal antitrust investigation into crop-biotechnology giant Monsanto Company as it contends with the loss of patent protection on its blockbuster soybean in 2014. Monsanto on Thursday received a formal demand from the Justice...
Big Concerns Regarding the PEW Report on Industrial Farm Animal Production
FASS Shares AVMA’s Concerns Regarding Pew Report on Industrial Farm Animal Production Posted January 5, 2010 The Federation of Animal Science Societies (FASS) has analyzed the Pew Commission on Industrial Farm Animal Production’s report Putting Meat on the Table: Industrial Farm Animal Production in America as well as the American Veterinary Medical...
Taking the “Human” out of “Humane”
A post from the Center for Consumer Freedom Posted January 5, 2010 We took a look last week at some details of the 2008 tax return filed by the deceptive Humane Society of the United States (HSUS). The filing shows that HSUS paid out less than one-half of one percent of its...
Terry D. Etherton I have spent the last few weeks attending many Holiday celebrations and receptions. A key component of these fabulous gatherings has been all of the delicious food. In addition, I have received many food gifts from family, friends and colleagues. We are deeply fortunate to live in a country...
2009 Year in Review: Scientists give their Opinion of Top News Stories in Agricultural Biotechnology
Council for Biotechnology Information Published December 16, 2009 With so many stories to choose from, it was hard for us to determine the top agricultural biotechnology story of 2009. Therefore, we turned to the Council for Biotechnology Information (CBI) experts and let them choose the top three stories that stood out in...
New Yorker Reporter Michael Specter Promotes Biotechnology and Science in Denialism
Michael Specter, a staff writer with the New Yorker, confronts the widespread fear of science and the negative impact it could have on scientific progress in the areas of global agriculture, health and nutrition in his new book Denialism: How Irrational Thinking Hinders Scientific Progress, Harms the Planet, and Threatens Our...
BMC Biotechnology - Latest Articles
Periplasmic expression of soluble single chain T cell receptors is rescued by the chaperone FkpA
Background: Efficient expression systems exist for antibody (Ab) molecules, which allow for characterization of large numbers of individual Ab variants. In contrast, such expression systems have been lacking for soluble T cell receptors (TCRs). Attempts to generate bacterial systems have generally resulted in low yields and material which is prone to...
Background: Penicillin G acylase of Escherichia coli (PGAEc) is a commercially valuable enzyme for which efficient bacterial expression systems have been developed. The enzyme is used as a catalyst for the hydrolytic production of beta-lactam nuclei or for the synthesis of semi-synthetic penicillins such as ampicillin, amoxicillin and cephalexin. To become...
A new approach to dual-color two-photon microscopy with fluorescent proteins
Background: Two-photon dual-color imaging of tissues and cells labeled with fluorescent proteins (FPs) is challenging because most two-photon microscopes only provide one laser excitation wavelength at a time. At present, methods for two-photon dual-color imaging are limited due to the requirement of large differences in Stokes shifts between the FPs used...
IntroductionSenescent cells are well-recognized in the aging/degenerating human disc. Senescent cells are viable, cannot divide, remain metabolically active and accumulate within the disc over time. Molecular analysis of senescent cells in tissue offers a special challenge since there are no cell surface markers for senescence which would let...
A novel FRET pair for detection of parallel DNA triplexes by the LightCycler
Background: Melting temperature of DNA structures can be determined on the LightCycler using quenching of FAM. This method is very suitable for pH independent melting point (Tm) determination performed at basic or neutral pH, as a high throughput alternative to UV absorbance measurements. At acidic pH quenching of FAM is not...
Background: The circadian rhythm in mammals is orchestrated by a central pacemaker in the brain, but most peripheral tissues contain their own intrinsic circadian oscillators. The circadian rhythm is a fundamental biological system in mammals involved in the regulation of various physiological functions such as behavior, cardiovascular functions and energy metabolism....
CropBiotech Update
Russia Approves Monsanto's Herbicide Tolerant Soybeans
Monsanto's herbicide tolerant genetically modified soybean MON89788 has been approved for food and processing in Russia. The soybean is the fourth GM soybean variety to be approved for food use in the country. As of the moment, there are 16 GM crops, including soybean, maize, rice and sugarbeet, approved for...
New Project Aims to Increase Yam Production in Africa
A project that aims to improve the capacity for yam research-for-development in West and Central Africa (WCA) has received a €750,000 (USD 1 million) grant from the European Union-African, Caribbean and Pacific Science and Technology Program (EU-ACP). The project, tagged Strengthening Capacity for Yam Research-for-Development in Central and Western......
Regulatory Reforms for Farmers to Benefit from GE Crops
Developing countries will need to develop and implement effective approaches to assess and manage the potential benefits and risks of genetically engineered crops. Costly regulatory delays can compromise technology delivery and hinder the commercialization of public-sector developed products. This view was forwarded by Jose Falck-Zepeda and collea......
Pakistan, Monsanto Sign MoU on Bt Cotton
The Pakistani Government aims to increase cotton production in the country through the introduction of insect-resistant Bt cotton, a report by the Daily Times says. In a meeting attended by representatives from the American seed giant Monsanto, officials from Pakistan's Ministry of Food and Agriculture (MINFA) and Ministry of Textile...
CIP Develops Enhanced Potato Varieties
The International Potato Center (CIP) and partner institutions are implementing a three-year project to develop potato varieties that can adapt to the drought and increased temperatures of Tajikistan, Uzbekistan, India, and Bangladesh. Their work is a response to the challenges of environmental constraints and climate change. Scientists are identif......
Secrets to Superb Malting Barleys Explored
USDA-ARS chemists March Schmitt and plant physiologist Allen Bunde have been studying the secrets of a good malt in barley. Malt is the delicious flavor or cereals, candies, beers and other foods and beverages. Barleys produce the malt as they germinate. The researchers are interested in the breaking down of...
biotechnology « WordPress.com Tag Feed
Braintree,Ma. LevelStock.com is pleased to announce today 5th Feb 2010, to all of its members and in...
Braintree,Ma. LevelStock.com is pleased to announce today 5th Feb 2010, to all of its members and in...
Braintree,Ma. LevelStock.com is pleased to announce today 5th Feb 2010, to all of its members and in...
Gajendra Reddy as a Project Assistant
Gajendra Reddy, R, MSc student of the batch, 2007-09 has got the admission in Osmania University, Hy...
Some day I’ll remember what I already know…if you push kids, but do it in a way that all...
Food crisis to hit the UK - and rest of world by 2070
A recent farming conference in Australia has revealed that as a result of over farming, fertile soil...
Biotech News
Dow, S&P Fall as Pfizer, Obama Reforms Weigh
Stocks mostly fell on Wednesday as Pfizer's disappointing outlook weighed on the health sector, and President Obama's pledge to complete banking and healthcare reform revived fears of increased regulation....
Vertex sees positive data in cystic fibrosis study
Vertex Pharmaceuticals Inc. said Wednesday its experimental cystic fibrosis drug VX-809 met key safety and tolerability goals in a midstage study....
Miss. settles Zyprexa suit for more than $18M
Mississippi will receive $18.5 million from drug maker Eli Lilly and Co. as part of a settlement over claims the company promoted the anti-psychotic Zyprexa for ailments it was not federally approved to treat, Attorney General Jim Hood said Thursday....
Coroner: Casey Johnson's death diabetes related
The Los Angeles County coroner says socialite Casey Johnson's death was related to diabetes....
GlaxoSmithKline Q4 Profit up 66 Pct
FILE - In this April 20, 2009 file photo, a sign for British pharmaceuticals firm GlaxoSmithKline is... FILE - In this April 20, 2009 file photo, a sign for British pharmaceuticals firm GlaxoSmithKline is seen on its offices, in London....
Poniard laying off staff, changing leadership
Poniard Pharmaceuticals said Wednesday it will lay off more than half its work force and replace CEO Jerry McMahon....
Bio Job Blog
Bristol Myers Squibb: Downsizing With a Twist
The past couple of weeks have been awful for employees at AstraZeneca and GlaxoSmithKline after both companies announced massive worldwide layoffs. Interestingly, the downsizing that has taken place at Bristol-Myers Squibb (BMS) in recent years has escaped notice; mainly because media attention has been focused on the sale of two...
Cruel and Unusual Punishment: "Debarking" Your Dog
There was a very disturbing article on the front page of today’s New York Time about an increasingly popular practice of debarking dogs by people who live in urban areas like New York City. Debarking is accomplished by severing a dog’s vocal cords. The practice may be more widespread than reported...
Job Cut Update: GlaxoSmithKline Mum on Number of US Jobs that will be Lost
Despite the announcement late last week in the London Sunday Times that GlaxoSmithKline (GSK) will eliminate 4000 jobs worldwide, company official are refusing to disclose the number of worker who will lose their jobs in the US. Cuts are expected throughout the US including GSK’s R&D facilities in the Philadelphia, ...
Why Generic Drug Companies Will Dominate Future Pharmaceutical Markets
The loss of over 200,000 pharmaceutical jobs over the past three years has been mainly driven by the anticipated loss of revenue from blockbuster drugs that will lose patent protection by 2013. While drug makers frequently cite blockbuster patent expiry as the reason for the need to downsize, they rarely...
The Carnage Continues: GlaxoSmithKline to Slash an Additional 4,000 Jobs
GlaxoSmithKline (GSK) Britain’s largest pharmaceutical company today announced it plans on slashing 4,000 jobs over the coming months. The bulk of the cuts will be in America and Europe, and are part of the company’s efforts to shift resources away from low-growth territories into parts of the world with greater...
What Do a New Award Winning Book and BioCrowd Have in Common?
Vincent Racaniello, virologist extraordinaire and a BioCrowd co-founder is slated to appear on ABC World News this evening to discuss Rebecca Sloot’s new book entitled The Immortal Life of Henrietta Lacks. The book details the life of little-known Henrietta Lack whose cancerous cervical cells (subsequently called HeLa cells by the scientists...
ScienceDaily: Biotechnology News
Shark virgin birth study shows offspring can survive long term
Shark pups born to virgin mothers can survive over the long-term, according to new research. The study shows for the first time that some virgin births can result in viable offspring....
Chemists discover how antiviral drugs bind to and block flu virus
Researchers have determined where an antiviral drug binds to and blocks a channel necessary for the flu virus to spread. The team also discovered that the drug spins in the channel, meaning there could be room for developing drugs that do a better job blocking the channel and stopping the...
Bad news for mosquitoes: Scent receptor research may lead to better traps, repellents
Researchers have found more than two dozen scent receptors in malaria-transmitting mosquitoes that detect compounds in human sweat, a finding that may help scientists to develop new ways to combat a disease that kills 1 million people annually....
Moss helps chart the conquest of land by plants
Clues to how the first land plants managed to avoid drying out might be provided by bryophytes, a group that includes the mosses, many of which retain remarkable drought tolerance. Some mosses can become so dry they crumble in the hand, but, if remoistened, will begin making proteins within minutes....
Tobacco plant-made therapeutic thwarts West Nile virus
A new therapeutic made from tobacco plants has been shown to arrest West Nile virus infection, according to a new study....
Heart patients using herbal remedies may be at heightened risk of dangerous drug interactions
More and more Americans are turning to herbal remedies to help manage chronic conditions or promote general health and wellness. But many of today's popular herbal supplements, including St. John's wort, gingko biloba, garlic and even grapefruit juice can pose serious risks to people who are taking medications for heart...
OnBioVC
Evolva (Switzerland) a clinical-stage synthetic biology small molecule company focused on proteinuri kidney and cardiovascular disease, closed a $15.2M Series B financing bringing the total round up to $42.3M. Participants include Wellington Partners, Aravis Venture Associates, Auriga Partners and Vinci Capital. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb...
On-Q-lty (Waltham, MA) a development stage molecular diagnostics company incorporating microfluidics and biomarker panels to predict response to cancer therapy based on DNA repair pathways in tumors, closed a $5M Series A financing, bringing the total round to $26M. Participants include Atlas Venture, Mohr Davidow Ventures, Bessemer Venture Partners, Physic...
Epizyme (Cambridge, MA) a development-stage biopharma company focused on histone methyltransferases inhibitors in oncology indications, closed a $8M Series B financings, bringing the total round to $40M. Participants include New Enterprise Associates, Bay City Capital, Amgen Ventures, Astellas Venture Partners, MPM Capital and Kleiner Perkins Caufield and Byers. Note: 2009...
Afferent Pharmaceuticals, Inc.: Series A $23M
Afferent Pharmaceuticals (Palo Alto, CA) a clinical-stage biopharmaceutical company focused on pain associated with conditions such as osteoarthritis, back pain, visceral pain and neuropathy, closed a $23M Series A financing. Participants include Third Rock Ventures, Pappas Ventures, Domain Associates and New Leaf Venture Partners. Note: 2009 Year-in-Review Trend Analysis Coming...
Molecular Partners, AG: Series B $45M
Molecular Partners (Switzerland) a preclinical-stage developing DARPins, a potential new class of protein therapeutics focused on ophthalmology indications, closed a $45M Series B financing. Participants include Essex Woodlands Health Ventures, Index Ventures, Johnson & Johnson Development Corp., BB Biotech Ventures and EndeavourVision. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb...
Ophthotech Corp.: Series B $30M
Ophthotech (Princeton, NJ) a clinical-stage biopharmaceutical company focused on ophthalmic therapies for wet and dry age-related macular degeneration, closed a $30M Series B financing. Participants include Clarus Ventures, SV Life Sciences, Novo Ventures and HBM BioVentures. Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb...
FierceBiotech
Abbott CEO White still interested in fresh acquisitions
Abbott Labs spent more than $10 billion on new acquisitions last year, but the company's CEO says his appetite for buyouts has yet to be completely sated. "We're obviously focused on the integration preparation for Solvay when it closes," says CEO Miles White (photo). "I don't in any way think that that...
Traders betting against Cell Therapeutics drug
Options traders are gambling heavily that a looming advisory review of Cell Therapeutics' cancer drug pixantrone is going to lead to some very bad news for the struggling developer. Bloomberg reports that the traders are making ‘unprecedented' bets that the company's shares are poised to drop. "A lot of people...
Lux files for Luveniq approval in U.S. and Europe
Backed by promising data from 450 patients in seven countries, Lux Biosciences has rapidly marched from the clinic to regulatory agencies in Europe and the U.S. with a marketing application for Luveniq--LX211--as a new treatment for non-infectious uveitis. "The results seen in the Luminate clinical trial program, the largest completed to...
Glaxo to shutter neurological programs, create rare diseases unit
Fueled by windfall profits from swine flu vaccine sales, GlaxoSmithKline reported a big spike in revenue for the fourth quarter. But the extra money hasn't stopped the pharma giant from sharpening its budget-cutting axe once again. Glaxo executives this morning outlined an additional 500 million pounds ($791.6 million) of budget cuts as...
Poniard unveils staff cuts, new CEO in restructuring
Faced with a series of disappointing trial results for its cancer drug picoplatin, a cash-strapped Poniard Pharmaceuticals has opted to axe more than half of its staff and named a new CEO to replace Jerry McMahon, who is staying on as nonexecutive chairman. South San Francisco-based Poniard tapped COO Ronald...
Pfizer to chop up to $3B from R&D budget
Signaling that Pfizer's "monolithic" approach to drug R&D is over, CEO Jeffrey Kindler laid out plans to carve $3 billion out of the newly merged company's budget for R&D as the pharma giant shifts away from its traditional reliance on in-house projects and opens itself more to partnerships and collaboration. Pfizer...
BioSpace.com Featured News and Stories
Syrris Establishes Brazilian Subsidiary
var addthis_pub"bdwyer";...
var addthis_pub"bdwyer";...
Genes In Mother, Baby Raise Risk Of Preterm Birth, Study
var addthis_pub"bdwyer";...
US FDA Warns Eli Lilly and Company, Sanofi-Aventis (France), Meda AB on Misleading Promotions
Reuters -- U.S. health officials have warned Sanofi Aventis SA, Eli Lilly & Co and Meda AB about misleading promotions for prescription drugs, letters released on Wednesday said....
The Scripps Research Institute Scientists Find Potential New Way to Enhance Vaccines
var addthis_pub"bdwyer";...
var addthis_pub"bdwyer";...
Bioresearch Online Products
Synergy H4 Hybrid Microplate Reader
SynergyT H4 with Hybrid TechnologyT is a patent-pending multi-mode detector that combines the optical systems of Synergy Mx and Synergy 2 in one compact instrument. It is the ideal instrument for research and drug discovery applications when having to choose between flexibility and performance is not an option....
Warehouse Services by Cherokee Pharmaceuticals LLC...
NanoDrop 2000/2000c Spectrophotometers
The New NanoDrop 2000 delivers the same high- quality performance you have come to expect from our full-spectrum UV-Vis instruments, and it provides many enhancements...
Laboratory Membrane Screening System- X-Flo76
Membrane screening system used in filtration steps for bioprocessing and separation of biomolecules (e.g. monoclonal antibodies)....
Laboratory Bioreactor Controllers
Applikon provides controllers to satisfy the requirements of bioreactors from laboratory research through production scale applications. Extending the concept of modularity you will be able to find a controller configured to satisfy the most demanding application....
IQ/OQ And GAMP-5 Equipment Validation Services
Provides detailed testing reports on all IQ/OQ validation procedures, as well as, all component manuals, test certificates and documentation...
Biotech Blog
Drug Patent Expirations in February 2010
Copyright © BiotechBlog.com, a product of thinkBiotech.com Drug Patent Expirations in February 2010 *Drugs may be covered by multiple patentsTradename Applicant Generic Name Patent Number Patent ExpirationZAGAM Mylan sparfloxacin 4,795,751 Feb 4, 2010TEVETEN Abbott eprosartan mesylate 5,185,351 Feb 9, 2010MYOVIEW Ge Healthcare technetium tc-99m tetrofosmin kit 5,045,302 Feb 9, 2010TEVETEN HCT Abbott eprosartan mesylate; hydrochlorothiazide 5,185,351 Feb 9, 2010HYZAAR Merck hydrochlorothiazide; losartan potassium 5,138,069*PED Feb 11, 2010COZAAR Merck losartan potassium 5,138,069*PED Feb 11, 2010EXUBERA Pfizer insulin recombinant human RE37872 Feb 12, 2010EXUBERA Pfizer insulin recombinant human RE38385 Feb...
Seeking new editorial board members for the Journal of Commercial Biotechnology
Copyright © BiotechBlog.com, a product of thinkBiotech.com Are you a leader in the biotechnology industry? Do you have specialized expertise and a strong network? I am looking for a few new members to join the Journal of Commercial Biotechnology’s editorial board. Board member responsibilities include authoring papers, soliciting papers, and reviewing papers....
How do you train your new biotechnology employees?
Copyright © BiotechBlog.com, a product of thinkBiotech.com I’m giving a talk at Pittcon on biotechnology training this spring. As many readers know, I have been very active in biotechnology education through my books and the classes I teach. So, I’ve got a strong sense of the supply-side of biotechnology education and...
Scientific American worldView Interview available
Copyright © BiotechBlog.com, a product of thinkBiotech.com Moira Gunn’s Tech Nation interview of Jeremy Abbate and I on the Scientific American worldView project is now available at IT Conversations. For more details, you can also see our video interview and the worldView website....
2010 Biotech Humanitarian Award
Copyright © BiotechBlog.com, a product of thinkBiotech.com I’m honored to have been selected as one of the judges of the 2010 Biotech Humanitarian award. More details are available in a press release and blog post about the award. The Biotechnology Industry Association created the Award to recognize an everyday hero who has...
Journal of Commercial Biotechnology — January 2010 issue now available
Copyright © BiotechBlog.com, a product of thinkBiotech.com The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper: Volume 16, Issue 1Time for a new business model? (free full-text) Yali Friedman Why data exclusivity is the new patent protection Peter Pitts Follow-on...
bio-technology « WordPress.com Tag Feed
A Key Step in Genetic Engineering? A Glowing Experiment By knowing how genes pass on instructions an...
From Extraordinary Leaders Come Extraordinary Measures
In a few days a dramatic motion picture that could shape politics in one state will be coming t...
http://www.the-scientist.com/videoawards/...
The Future of Brain Controlled Devices: CNN Article
http://www.cnn.com/2009/TECH/12/30/brain.controlled.computers/index.html...
Genetic and bio-technology conference held
Courtesy by: gulfnews.com A large population of the UAE suffers from genetic disorders, including co...
Multireal. David Louis Edelman
This book is the second in the Jump 225 trilogy, following Infoquake. It is very much part of a tril...
<< 1 >>